RiverWalk Therapeutics
Biotechnology Research • 
San Antonio, Texas, United States • 1-10 Employees
Company overview
| Headquarters | San Antonio, Texas, United States |
| Website | |
| NAICS | 541714 |
| Keywords | Immunotherapy, Kidney Cancer, Triple Negative Breast Cancer, Metastasis, Adenosine, Non-Small Cell Lung Cancer, Bone Metastasis, Liver Metastasis |
| Founded | 2019 |
| Employees | 1-10 |
| Socials |
Key Contact at RiverWalk Therapeutics
Jean Jiang
Founder and CSO
RiverWalk Therapeutics Email Formats
RiverWalk Therapeutics uses 1 email format. The most common is {last name}{last name} (e.g., doedoe@riverwalktherapeutics.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{last name}{last name} | doedoe@riverwalktherapeutics.com | 100% |
About RiverWalk Therapeutics
RiverWalk Therapeutics is a women-owned, women-led preclinical biotech developing game-changing therapies for metastatic cancers where existing therapies are limited, toxic and ineffective. Our lead program is small molecule inhibitors of adenosine A2A/A2B receptors for late-stage, immunogenic cancers with a known correlation of A2B overexpression and poor outcomes, such as triple negative breast cancer (TNBC). Our drug candidate, RW-108, is a first-in-class dual A2A/A2B inverse agonist that has demonstrated good drug characteristics and potent effects in multiple metastatic TNBC models.
RiverWalk Therapeutics revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
RiverWalk Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
RiverWalk Therapeutics has never raised funding before.
Sweden
United Kingdom
Frequently asked questions
4.8
40,000 users
